Table 1.
Cohort | N | Age mean ± SD | Male/Female | Patients (%) |
---|---|---|---|---|
Parkinson’s disease and Parkinsonism | 36 | 72.1 ± 8.8 | 26/10 | 22 |
Poststroke | 31 | 68.2 ± 14.1 | 24/7 | 19 |
Multiple Sclerosis | 9 | 53.1 ± 12.2 | 2/7 | 5 |
Traumatic Brain Injury | 10 | 40.3 ± 20.1 | 6/4 | 6 |
Other neurological | 42 | 65.1 ± 18.2 | 23/19 | 25 |
Non-neurological | 39 | 65.5 ± 21.0 | 18/21 | 23 |
Total | 167 | 63.8 ± 18.9 | 99/68 | 100 |
Data analysis was based only on initial treatments for each patient (167, highlighted). Other neurological conditions included patients with myelopathy (n = 19), polyneuropathy (n = 5), cerebral palsy (n = 4), polio (n = 4), Guillain-Barre syndrome (n = 2), vertigo (n = 3), ataxia (n = 2), cerebellar ataxia (n = 1), vestibular Schwannoma (n = 1), and hyperekplexia (n = 1). Non-neurological conditions included patients with recurrent falls (n = 15), cancer (n = 11), non-neurological gait abnormality (n = 5), lower limb injury (n = 3), above-knee amputation (n = 3), low back pain (n = 1), and polymyalgia rheumatica (n = 1).